Patch-Pump Hopefuls Aim for a Piece of the Pie
Growing demand for insulin patch pumps in the US—a market currently dominated by Insulet and the Omnipod 5—has ignited a firestorm of activity among would-be competitors, including Medtronic, Tandem Diabetes Care, Roche, and embecta, along with innovative smaller companies such as PharmaSens, Modular Medical, and ViCentra—all aiming to shake up the status quo.
Read Article